Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Adenocarcinoma”

1,169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,169 results

Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Large-scale testing (Phase 3)Ended earlyNCT00024167
What this trial is testing

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 265
Large-scale testing (Phase 3)Study completedNCT00003367
What this trial is testing

Diet and PSA Levels in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 154
Testing effectiveness (Phase 2)Looking for participantsNCT05806515
What this trial is testing

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8
SWOG Cancer Research Network 44
Testing effectiveness (Phase 2)Study completedNCT00087035
What this trial is testing

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06616597
What this trial is testing

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Testing effectiveness (Phase 2)Ended earlyNCT00448097
What this trial is testing

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 7
Large-scale testing (Phase 3)WithdrawnNCT00258466
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Not applicableActive Not RecruitingNCT06995053
What this trial is testing

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 91
Not applicableUnknownNCT03284151
What this trial is testing

Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

Who this might be right for
Prostate Cancer
Centre Francois Baclesse, Luxembourg 26
Testing effectiveness (Phase 2)Ended earlyNCT05689021
What this trial is testing

CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 8
Not applicableStudy completedNCT01542021
What this trial is testing

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate CancerProstatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT04288687
What this trial is testing

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 11
Early research (Phase 1)Study completedNCT00403221
What this trial is testing

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Baylor College of Medicine 19
Large-scale testing (Phase 3)Study completedNCT05197257
What this trial is testing

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Colorado, Denver 39
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Not applicableLooking for participantsNCT04146077
What this trial is testing

Active Surveillance for Low Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
I.M. Sechenov First Moscow State Medical University 100
Next Page